Patient-reported outcomes: A 5-year long study reveals previously unreported therapeutic, demographic, socio-economic, and other correlations in vitiligo
- 25 September 2018
- journal article
- research article
- Published by Wiley in Dermatologic Therapy
- Vol. 31 (5) , e12620
Abstract
Vitiligo is a non‐lethal, non‐communicable, immune‐mediated, and generally progressive skin disease, with poorly understood etiopathogenesis and weak evidence base. The aim of the study is to contribute to the scant research on the patient‐reported outcomes in vitiligo, and to examine the presence of associations between various inputs for possible use in clinical practice. The study was designed as a web‐based questionnaire with 40 inputs across seven dimensions. The questions include demographics, skin type, eye and natural hair color, age of respondent and age of onset, possible triggers, disease extent, localization, progression and activity, the efficacy of most common treatment modalities, medication side‐effects, heredity and diseases among parents, and out‐of‐pocket expenses for treatments to date. The analysis presented with this work contributes to the discussion about the relation between therapies, socio‐economic factors, and treatment outcomes in vitiligo. All physicians should adequately manage patient expectations in terms of overall treatment duration and expected out‐of‐pocket expenses, and actively evaluate patients at shorter intervals. A more aggressive therapeutic approach using telehealth devices should be considered to supplement therapy, monitor treatment progress, and protocol compliance.Keywords
Funding Information
- 501(c)3 non-profit Vitiligo Research Foundation
This publication has 37 references indexed in Scilit:
- Vitiligo road mapDermatologic Therapy, 2012
- Willingness to Pay in Dermatology: Assessment of the Burden of Skin DiseasesJournal of Investigative Dermatology, 2012
- A review of the worldwide prevalence of vitiligo in children/adolescents and adultsInternational Journal of Dermatology, 2012
- Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus ConferencePigment Cell & Melanoma Research, 2012
- Six Decades of Vitiligo Genetics: Genome-Wide Studies Provide Insights into Autoimmune PathogenesisJournal of Investigative Dermatology, 2012
- Willingness-to-pay and quality of life in patients with vitiligoBritish Journal of Dermatology, 2009
- The burden of skin diseases: 2004Journal of the American Academy of Dermatology, 2006
- Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligoPigment Cell Research, 2005
- Barriers to patient-physician communication about out-of-pocket costsJournal of General Internal Medicine, 2004
- Depigmentation therapyDermatologic Therapy, 2001